At the prison hospital inside the California Men’s Colony near San Luis Obispo, 75-year-old Floyd Masterson is waiting to pick up some medication. He carries a walking stick in one hand and a pink appointment slip in the other. Like the rest of the inmates around him, he’s dressed in a dark blue prison uniform. He has something else in common with many prisoners: hepatitis C. The disease affects about 1 percent of the country’s population as a whole, but 17 percent of those in prison.
G. Scott Gazelle, MD, MPH, PhD, ITA director emeritus and vice chair for Faculty Affairs in the Department of Radiology, has received the 2016 Radiology Alliance for Health Services Research Achievement Award. The award honors the achievements of an individual who has made significant contributions to the field of health services research in radiology. Gazelle received the award during the Association of University Radiologists Annual Meeting.
(HealthDay)—The burden of hepatitis C virus (HCV) and associated disease is projected to remain considerable even in the era of oral direct-acting antivirals (DAAs), according to a study published online March 25 in Hepatology.